These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24708172)

  • 1. Visualizing dermal permeation of sodium channel modulators by mass spectrometric imaging.
    Eberlin LS; Mulcahy JV; Tzabazis A; Zhang J; Liu H; Logan MM; Roberts HJ; Lee GK; Yeomans DC; Du Bois J; Zare RN
    J Am Chem Soc; 2014 Apr; 136(17):6401-5. PubMed ID: 24708172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective sodium channel blockers promise a new era of pain research.
    Priest BT; Kaczorowski GJ
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8205-6. PubMed ID: 17488822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on cutaneous permeation in vitro of Kushen recipe gel].
    Peng C; Hu JH; Zhu QG; Liu JY; Qin Z; Wang J
    Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1870-4. PubMed ID: 18051892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SAR.
    Bregman H; Nguyen HN; Feric E; Ligutti J; Liu D; McDermott JS; Wilenkin B; Zou A; Huang L; Li X; McDonough SI; Dimauro EF
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2033-42. PubMed ID: 22306122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted biaryl pyrazoles as sodium channel blockers.
    Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5480-3. PubMed ID: 20709545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
    Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazopyridines: a novel class of hNav1.7 channel blockers.
    London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel class of biphenyl pyrazole sodium channel blockers for treatment of neuropathic pain.
    Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Eid R; Fisher MH; Parsons WH; Wyvratt MJ; Lyons KA; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Weber A; Duffy JL
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7479-82. PubMed ID: 21106456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of rat skin as a substitute for human skin in the in vitro skin permeation study.
    Takeuchi H; Mano Y; Terasaka S; Sakurai T; Furuya A; Urano H; Sugibayashi K
    Exp Anim; 2011; 60(4):373-84. PubMed ID: 21791877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and Pharmacokinetics of the Sodium Channel Blocking Toxins (Saxitoxin and the Tetrodotoxins).
    Pratheepa V; Vasconcelos V
    Mini Rev Med Chem; 2017; 17(4):320-327. PubMed ID: 27306745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine.
    Cao FH; OuYang WQ; Wang YP; Yue PF; Li SP
    Arch Pharm Res; 2011 Apr; 34(4):551-62. PubMed ID: 21544720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.
    Ok D; Li C; Abbadie C; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Martin WJ; Priest BT; Smith MM; Williams BS; Wyvratt MJ; Parsons WH
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1358-61. PubMed ID: 16337121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway drug pharmacokinetics via analysis of exhaled breath condensate.
    Esther CR; Boucher RC; Johnson MR; Ansede JH; Donn KH; O'Riordan TG; Ghio AJ; Hirsh AJ
    Pulm Pharmacol Ther; 2014 Feb; 27(1):76-82. PubMed ID: 23932897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical and transdermal delivery of caffeine.
    Luo L; Lane ME
    Int J Pharm; 2015 Jul; 490(1-2):155-64. PubMed ID: 26004004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of chemical dermal absorption by 14 natural products: a quantitative structure permeation analysis of components often found in topical preparations.
    Muhammad F; Jaberi-Douraki M; de Sousa DP; Riviere JE
    Cutan Ocul Toxicol; 2017 Sep; 36(3):237-252. PubMed ID: 27825281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application.
    Dancik Y; Anissimov YG; Jepps OG; Roberts MS
    Br J Clin Pharmacol; 2012 Apr; 73(4):564-78. PubMed ID: 21999217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium.
    Maurya A; Murthy SN
    J Pharm Sci; 2014 May; 103(5):1497-503. PubMed ID: 24644068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.
    Scanio MJ; Shi L; Drizin I; Gregg RJ; Atkinson RN; Thomas JB; Johnson MS; Chapman ML; Liu D; Krambis MJ; Liu Y; Shieh CC; Zhang X; Simler GH; Joshi S; Honore P; Marsh KC; Knox A; Werness S; Antonio B; Krafte DS; Jarvis MF; Faltynek CR; Marron BE; Kort ME
    Bioorg Med Chem; 2010 Nov; 18(22):7816-25. PubMed ID: 20965738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of formulation effects on dermal absorption of topically applied ectoparasiticides dosed in vitro on canine and porcine skin using a mixture-adjusted quantitative structure permeability relationship.
    Riviere JE; Brooks JD; Collard WT; Deng J; de Rose G; Mahabir SP; Merritt DA; Marchiondo AA
    J Vet Pharmacol Ther; 2014 Oct; 37(5):435-44. PubMed ID: 24649911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a human physiologically based pharmacokinetic (PBPK) model for dermal permeability for lindane.
    Sawyer ME; Evans MV; Wilson CA; Beesley LJ; Leon LS; Eklund CR; Croom EL; Pegram RA
    Toxicol Lett; 2016 Mar; 245():106-9. PubMed ID: 26794662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.